First Quadrant’s Bio-Techne TECH Stock Holding History

First Quadrant’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,228	Closed	-$580K	–	828
2020 Q1	$580K	Sell	12,228 -9,736	-44%	-$487K	0.08%	238
2019 Q4	$1.21M	Hold	21,964	–	–	0.1%	200
2019 Q3	$1.07M	Sell	21,964 -2,584	-11%	-$130K	0.1%	215
2019 Q2	$1.28M	Buy	+24,548	New	+$1.24M	0.09%	258
2016 Q4	–	Sell	-4	Closed	–	–	908
2016 Q3	$0	Buy	+4	New	+$110	﹤0.01%	912

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

First Quadrant's TECH Position: Q2 2020 in Review

First Quadrant sold out of Bio-Techne (TECH) in Q2 2020, closing a stake of 12,228 shares — an estimated $580K sold.

First Quadrant first reported a position in TECH in Q3 2016 and held it in 5 quarters. The position peaked at $1.28M in Q2 2019. 393 funds tracked by Wall St. Rank hold TECH as of Q2 2020.

First Quadrant reported no remaining Bio-Techne position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 12,228 Bio-Techne shares in Q2 2020, an estimated $580K.
First Quadrant first reported a position in Bio-Techne in Q3 2016 and held it in 5 quarters.
First Quadrant's Bio-Techne position peaked at $1.28M in Q2 2019.
393 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.